Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) Proposers' Day Special Notice
SOL #: ARPA-H-SN-26-139Special Notice
Overview
Buyer
Health And Human Services
National Institutes Of Health
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Washington, DC, 20005, United States
Place of Performance
Washington, DC
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
PSC
Health R&D Services; Health Care Services; Experimental Development (AN13)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Jan 13, 2026
2
Last Updated
Jan 15, 2026
3
Action Date
Jan 21, 2026, 10:00 PM
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
This Special Notice (SN) is intended to alert the scientific community to an Advanced Research Projects Agency for Health (ARPA-H) program and notify potential proposers of associated Proposers’ Day (PD). The Scalable Solutions Office (SSO) within ARPA-H published the Innovative Solutions Opening (ISO) for the Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) program (ARPA-H-SOL-26-142) on January 13, 2026.
See attached SN ARPA-H-SN-26-139 for further details.
People
Points of Contact
Unnamed ContactPRIMARY
Files
Files
No files attached to this opportunity
Versions
Version 2
Special Notice
Posted: Jan 15, 2026
Version 1Viewing
Special Notice
Posted: Jan 13, 2026